104 related articles for article (PubMed ID: 20433998)
1. Thromboprophylaxis during chemotherapy: NO.
Levine MN
Thromb Res; 2010 Apr; 125 Suppl 2():S16. PubMed ID: 20433998
[No Abstract] [Full Text] [Related]
2. [The use of anticoagulants in the chemotherapy of cancer].
Grekh IF; Shats VIa
Vopr Onkol; 1969; 15(1):111-6. PubMed ID: 4891306
[No Abstract] [Full Text] [Related]
3. Venous thromboembolism and cancer.
Bergqvist D; Caprini JA; Dotsenko O; Kakkar AK; Mishra RG; Wakefield TW
Curr Probl Surg; 2007 Mar; 44(3):157-216. PubMed ID: 17437761
[No Abstract] [Full Text] [Related]
4. Thromboprophylaxis for caesarean section--how can uptake and coverage be improved?
Gidiri M; Sant M; Philips K; Lindow SW
J Obstet Gynaecol; 2004 Jun; 24(4):392-4. PubMed ID: 15203578
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
6. Thromboprophylaxis.
Bailey S; Campbell J; Haines S
J Neurosurg; 2002 Apr; 96(4):807-8; author reply 808-9. PubMed ID: 11990828
[No Abstract] [Full Text] [Related]
7. Thromboprophylaxis.
Walsh DC; Kakkar AK
J Neurosurg; 2002 Apr; 96(4):806-7; author reply 807. PubMed ID: 11990827
[No Abstract] [Full Text] [Related]
8. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Semin Thromb Hemost; 2002 Feb; 28(1):45-52. PubMed ID: 11885025
[TBL] [Abstract][Full Text] [Related]
9. [Initial trials give hope. Anticoagulants against cancer?].
Hiller E
MMW Fortschr Med; 2003 Apr; 145(14):16. PubMed ID: 15072270
[No Abstract] [Full Text] [Related]
10. Barriers to the optimal use of anticoagulants after orthopaedic surgery.
Borris LC
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1441-5. PubMed ID: 18841341
[TBL] [Abstract][Full Text] [Related]
11. Complications from vascular disrupting agents and angiogenesis inhibitors: aberrant control of hemostasis and thrombosis.
van Heeckeren WJ; Sanborn SL; Narayan A; Cooney MM; McCrae KR; Schmaier AH; Remick SC
Curr Opin Hematol; 2007 Sep; 14(5):468-80. PubMed ID: 17934353
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulants in thrombosis and cancer: the missing link.
Mousa SA
Expert Rev Anticancer Ther; 2002 Apr; 2(2):227-33. PubMed ID: 12113244
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis and cancer: Trousseau syndrome revisited.
Donati MB
Best Pract Res Clin Haematol; 2009 Mar; 22(1):3-8. PubMed ID: 19285268
[TBL] [Abstract][Full Text] [Related]
14. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy.
Levine MN
Thromb Haemost; 1997 Jul; 78(1):133-6. PubMed ID: 9198142
[TBL] [Abstract][Full Text] [Related]
15. Appropriate thromboprophylaxis in hospitalized cancer patients.
Amin A; Stemkowski S; Lin J; Yang G
Clin Adv Hematol Oncol; 2008 Dec; 6(12):910-20. PubMed ID: 19209141
[TBL] [Abstract][Full Text] [Related]
16. Audit of thromboprophylaxis in women undergoing caesarean section.
Khan R; Byrne P
Ir Med J; 2004 Mar; 97(3):72-4. PubMed ID: 15164686
[TBL] [Abstract][Full Text] [Related]
17. Prevention of venous thromboembolism in cancer patients.
Kakkar AK; Williamson RC
Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
[TBL] [Abstract][Full Text] [Related]
18. [Pathophysiology of chemotherapy-associated thrombosis].
Lechner D; Weltermann A
Hamostaseologie; 2009 Jan; 29(1):112-20. PubMed ID: 19151860
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiogenesis: thalidomide or low-molecular-weight heparin?
Ozkan M; Eser B; Er O; Dogu GG; Altinbas M
J Clin Oncol; 2005 Mar; 23(9):2113; author reply 2113-4. PubMed ID: 15774812
[No Abstract] [Full Text] [Related]
20. Clinical studies with anticoagulants to improve survival in cancer patients.
Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
